CARGO Therapeutics (CRGX) Competitors $15.82 -0.29 (-1.80%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends CRGX vs. XENE, HCM, VERA, MOR, SWTX, KYMR, VCEL, GMTX, ACAD, and AMRXShould you be buying CARGO Therapeutics stock or one of its competitors? The main competitors of CARGO Therapeutics include Xenon Pharmaceuticals (XENE), HUTCHMED (HCM), Vera Therapeutics (VERA), MorphoSys (MOR), SpringWorks Therapeutics (SWTX), Kymera Therapeutics (KYMR), Vericel (VCEL), Gemini Therapeutics (GMTX), ACADIA Pharmaceuticals (ACAD), and Amneal Pharmaceuticals (AMRX). These companies are all part of the "pharmaceutical products" industry. CARGO Therapeutics vs. Xenon Pharmaceuticals HUTCHMED Vera Therapeutics MorphoSys SpringWorks Therapeutics Kymera Therapeutics Vericel Gemini Therapeutics ACADIA Pharmaceuticals Amneal Pharmaceuticals Xenon Pharmaceuticals (NASDAQ:XENE) and CARGO Therapeutics (NASDAQ:CRGX) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, media sentiment, dividends, analyst recommendations, community ranking and valuation. Do institutionals & insiders have more ownership in XENE or CRGX? 95.5% of Xenon Pharmaceuticals shares are held by institutional investors. Comparatively, 93.2% of CARGO Therapeutics shares are held by institutional investors. 5.5% of Xenon Pharmaceuticals shares are held by insiders. Comparatively, 1.4% of CARGO Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media favor XENE or CRGX? In the previous week, Xenon Pharmaceuticals had 24 more articles in the media than CARGO Therapeutics. MarketBeat recorded 28 mentions for Xenon Pharmaceuticals and 4 mentions for CARGO Therapeutics. CARGO Therapeutics' average media sentiment score of 0.27 beat Xenon Pharmaceuticals' score of 0.07 indicating that CARGO Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Xenon Pharmaceuticals 6 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral CARGO Therapeutics 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger valuation and earnings, XENE or CRGX? CARGO Therapeutics has lower revenue, but higher earnings than Xenon Pharmaceuticals. Xenon Pharmaceuticals is trading at a lower price-to-earnings ratio than CARGO Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioXenon Pharmaceuticals$9.43M318.06-$182.39M-$2.82-13.95CARGO TherapeuticsN/AN/A-$98.15M-$4.26-3.71 Do analysts prefer XENE or CRGX? Xenon Pharmaceuticals presently has a consensus price target of $57.45, indicating a potential upside of 46.05%. CARGO Therapeutics has a consensus price target of $30.33, indicating a potential upside of 91.74%. Given CARGO Therapeutics' higher possible upside, analysts plainly believe CARGO Therapeutics is more favorable than Xenon Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Xenon Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 3.08CARGO Therapeutics 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is XENE or CRGX more profitable? Xenon Pharmaceuticals' return on equity of -24.69% beat CARGO Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Xenon PharmaceuticalsN/A -24.69% -23.68% CARGO Therapeutics N/A -38.16%-33.94% Does the MarketBeat Community believe in XENE or CRGX? Xenon Pharmaceuticals received 405 more outperform votes than CARGO Therapeutics when rated by MarketBeat users. However, 100.00% of users gave CARGO Therapeutics an outperform vote while only 69.90% of users gave Xenon Pharmaceuticals an outperform vote. CompanyUnderperformOutperformXenon PharmaceuticalsOutperform Votes41869.90% Underperform Votes18030.10% CARGO TherapeuticsOutperform Votes13100.00% Underperform VotesNo Votes SummaryXenon Pharmaceuticals beats CARGO Therapeutics on 11 of the 16 factors compared between the two stocks. Ad DarwinNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! Get CARGO Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRGX vs. The Competition Export to ExcelMetricCARGO TherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$741.51M$2.95B$5.06B$8.89BDividend YieldN/A1.90%4.97%4.06%P/E Ratio-3.7117.8689.0213.30Price / SalesN/A222.321,207.2881.01Price / CashN/A160.0839.1736.03Price / Book1.824.906.085.74Net Income-$98.15M-$41.63M$119.07M$225.93M7 Day Performance-6.94%-4.73%-1.84%-1.32%1 Month Performance-24.52%-6.53%-3.65%0.60%1 Year Performance9.10%25.63%31.62%26.23% CARGO Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRGXCARGO Therapeutics1.6683 of 5 stars$15.82-1.8%$30.33+91.7%+8.0%$741.51MN/A-3.71116XENEXenon Pharmaceuticals3.4958 of 5 stars$39.34+1.3%$57.45+46.0%+35.2%$2.96B$9.43M0.00251Analyst RevisionHCMHUTCHMED1.1549 of 5 stars$17.96+7.2%$20.55+14.4%-3.1%$2.92B$838M0.001,988Analyst DowngradeNews CoverageGap UpVERAVera Therapeutics3.3108 of 5 stars$45.75-0.3%$57.88+26.5%+238.9%$2.91BN/A0.0040MORMorphoSys0.1673 of 5 stars$18.96flat$10.48-44.8%N/A$2.86B$238.28M-5.45730SWTXSpringWorks Therapeutics2.0472 of 5 stars$37.44-1.3%$67.00+79.0%+68.5%$2.82B$5.45M0.00305Analyst ForecastKYMRKymera Therapeutics1.4071 of 5 stars$44.05+2.8%$52.13+18.4%+110.9%$2.77B$78.59M0.00170Analyst ForecastVCELVericel1.0623 of 5 stars$57.26+2.6%$58.14+1.5%+56.1%$2.76B$226.84M954.33300Analyst ForecastGMTXGemini TherapeuticsN/A$62.55+5.0%N/A+14.7%$2.71BN/A-62.5530ACADACADIA Pharmaceuticals3.9106 of 5 stars$16.27+0.4%$25.56+57.1%-29.0%$2.71B$726.44M20.86510Insider TradeAnalyst RevisionAMRXAmneal Pharmaceuticals2.9437 of 5 stars$8.41-0.4%$10.00+18.9%+86.9%$2.61B$2.39B0.007,700Insider Trade Related Companies and Tools Related Companies XENE Competitors HCM Competitors VERA Competitors MOR Competitors SWTX Competitors KYMR Competitors VCEL Competitors GMTX Competitors ACAD Competitors AMRX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CRGX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CARGO Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CARGO Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRGX Stock Alerts